Physiogenex is a preclinical contract research organization (CRO) that offers outstanding consultancy and research services, specializing inmetabolic disorders such as diabetes, obesity,liver diseases (NASH), dyslipidemia,atherosclerosis and cardiovascular complications.

More than just a CRO, we are your R&D partner of choice to target your specific needs. Our models and technologies are customized and we deliver unparalleled scientific expertise for R&D, preclinical development, post-marketing studies and drug repositioning. We also offer in vivo preclinical imaging services.

We provide both the biopharmaceutical and nutraceutical companies with optimal and reliable solutions for successful strategic decision-making.